Hugo Aerts (@hugoaerts) 's Twitter Profile
Hugo Aerts

@hugoaerts

Professor @Harvard | Director, AI in Medicine (AIM) @MassGenBrigham I Professor @MaastrichtU (account retired)

ID: 3113549318

linkhttp://aim.hms.harvard.edu/hugo-aerts calendar_today28-03-2015 20:34:12

90 Tweet

686 Followers

265 Following

Ray Mak, MD (@dr_raymak) 's Twitter Profile Photo

T2. In this commentary in The Lancet Digital Health, we use an #AI in medicine/autonomous car analogy, to develop a corollary to DoT definitions of levels of AI autonomy with consideration of liability based on risk. Danielle Bitterman, MD Hugo Aerts #RadAIchat thelancet.com/journals/landi…

T2. In this commentary in <a href="/LancetDigitalH/">The Lancet Digital Health</a>, we use an #AI in medicine/autonomous car analogy, to develop a corollary to DoT definitions of levels of AI autonomy with consideration of liability based on risk.    <a href="/dbittermanmd/">Danielle Bitterman, MD</a> <a href="/HugoAerts/">Hugo Aerts</a> #RadAIchat thelancet.com/journals/landi…
Charles Swanton (@charlesswanton) 's Twitter Profile Photo

Cachexia is a devastating condition in patients with cancer. Our study on cancer cachexia in #TRACERx is out today in Nature Medicine led by Othman Al-Sawaf, @MariamJHanjani, Swanton Lab: nature.com/articles/s4159… Key results in a brief 🧵

Charles Swanton (@charlesswanton) 's Twitter Profile Photo

Excited to share our TRACERx nature publication on circulating tumor DNA (#ctDNA, #MRD) detection in resectable lung cancer led by @AbboshChris, @Afrankell, Judit Kisistok, Thomas Harrison, Aaron Garnett, Nicolai Birkbak and Nicholas McGranahan 👇👇👇 Tweetorial🧵 nature.com/articles/s4158…

Danielle Bitterman, MD (@dbittermanmd) 's Twitter Profile Photo

Is ChatGPT a reliable source for cancer treatment recommendations 🤖? Our study, out now in JAMA Oncology, found that the chatbot included guideline non-concordant recommendations for common cancer diagnoses 1/3 of the time: jamanetwork.com/journals/jamao… #ChatGPT #LLM #NLProc

Danielle Bitterman, MD (@dbittermanmd) 's Twitter Profile Photo

Thanks for highlighting the studies - We are still in early days but so much potential. Looking forward to working towards responsible and equitable AI for healthcare as outlined in Atul Butte's wonderful editorial!

Ray Mak, MD (@dr_raymak) 's Twitter Profile Photo

1/ Check out this preprint that describes how we developed and validated a new #AI-based biomarker that we are calling “FaceAge”, which uses a simple face #photo to predict outcomes in #cancer patients! medrxiv.org/content/10.110… #oncology #AImedicine #FaceAge

Hugo Aerts (@hugoaerts) 's Twitter Profile Photo

I'm excited to share a groundbreaking approach leveraging foundation models to develop high-performance radiomic biomarkers, even when confronted with limited training data. Check out our work in Nature Machine Intelligence: nature.com/articles/s4225…

Eric Topol (@erictopol) 's Twitter Profile Photo

Chest x-rays, the most frequently performed imaging test in medicine, have rich embedded information that humans can't see. Here #AI detects 10-year cardiovascular risk as well as the traditional (ASCVD) score! acpjournals.org/doi/10.7326/M2… Karl Jakob Weiss Vineet Raghu @kparuchur

Chest x-rays, the most frequently performed imaging test in medicine, have rich embedded information that humans can't see. Here #AI detects 10-year cardiovascular risk as well as the traditional (ASCVD) score!
acpjournals.org/doi/10.7326/M2…
 <a href="/karljakobweiss/">Karl Jakob Weiss</a> <a href="/VineetRaghu2/">Vineet Raghu</a> @kparuchur
Danielle Bitterman, MD (@dbittermanmd) 's Twitter Profile Photo

Cross-Care is our new #LLM benchmark for measuring safety/bias in the #healthcare domain. We find misalignments between real biomedical facts, pretraining data, and LLM knowledge representation. Read more (arxiv.org/abs/2405.05506) and explore our website (crosscare.net)

Cross-Care is our new #LLM benchmark for measuring safety/bias in the #healthcare domain. We find misalignments between real biomedical facts, pretraining data, and LLM knowledge representation. Read more (arxiv.org/abs/2405.05506) and explore our website (crosscare.net)
Mass General Brigham (@massgenbrigham) 's Twitter Profile Photo

Did you know your face can reveal your biological age? Mass General Brigham Research has developed FaceAge, an #AI algorithm that predicts biological age survival outcomes for patients with cancer using a single photo. Patients with cancer appeared five years older than their actual age, and

Mass General Brigham Research (@mgbresearchnews) 's Twitter Profile Photo

Did you know your face can reveal your biological age? Researchers at Mass General Brigham developed FaceAge, an #AI algorithm that predicts biological age and survival outcomes for patients with cancer using a single photo. Patients with cancer appeared five years older than their